The funding will be available to members of the Association of Community Cancer Centers, a cancer care provider advocacy group.

CMS will reimburse FoundationOne CDx at a rate of $3,500 per test for a nine-month period starting July 1.

The group will combine VIB's sequencing technology with Verge's machine learning platform to study banked tissue samples at UCSD in a drug discovery effort.

The NGS-based test improves on a previous PCR-based version and detects circulating DNA from Epstein Barr virus that is shed from cancer cells.

Researchers described diet-related patterns of gut microbial diversity, microbiome ties to psychiatric disease, and more.

Using bioinformatic and molecular cytogenetic approaches, researchers retraced ancestral "diapsid" reptile genome patterns from extant bird and reptile genomes.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.

May
08
Sponsored by
Applied Spectral Imaging

The introduction of digital pathology has opened the door to countless new possibilities. Whole Slide
Imaging, computational image analysis and automated workflows are redefining pathology and shaping
the future of cancer care. Join us as we review new applications in digital pathology which provide the
necessary tools pathologists need in order to meet the growing demands of modern pathology.

The BD Rhapsody Single-Cell Analysis System empowers and streamlines single-cell research with a complete system of tools, including reagents and analysis software, that work together to meet neuroscience experimental needs. Neuroscientists’ ability to identify and characterize individual cells in the nervous system opens the door to finding pathogenic cells, regenerative cells, and pathways that drug manufacturers can exploit for the discovery of therapeutics for neurodegenerative disease.

As the field of therapeutic antibody research expands, scientists face a growing need for software that enables them to efficiently and accurately analyze their data. Highly functional bioinformatics software solutions significantly reduce the need to manually curate sequence data or convert it into different formats for sharing and archiving. Unfortunately, there are currently few specialist antibody screening and analysis platforms that can be quickly configured to meet the highly custom needs of specialized therapeutic antibody discovery organizations.